Perrier A, Boelle PY, Chretien Y, Gligorov J, et al. An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies. PLoS One 2020;15:e0227356.
PMID: 31910438